The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Annual Meeting Preview: Effective Advocacy By & For ACR/ARP Members

Annual Meeting Preview: Effective Advocacy By & For ACR/ARP Members

October 3, 2019 • By Mary Beth Nierengarten

  • Tweet
  • Email
Print-Friendly Version / Save PDF

The ACR Government Affairs Committee has been hard at work advocating on behalf of members regarding issues critical for rheumatology practices and patients.

You Might Also Like
  • Hot Topics, Fresh Formats: ACR/ARP Annual Meeting Clinical Session Preview
  • Annual Meeting Preview: Maximizing Reimbursement Under MACRA, MIPS & APMs
  • Sit Back & Enjoy Learning at the 2019 ACR/ARP Annual Meeting
Also By This Author
  • A New Treatment for Axial Spondyloarthritis?

At the 2019 ACR/ARP Annual Meeting, members can hear more about key accomplishments from the past year in a session titled Raise Your Voice! Advocacy Update from Government Affairs, scheduled for 1 p.m. on Monday, Nov. 11.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Attendees will also hear a message that should resonate from previous years: The success of advocacy work depends on active participation of all ACR/ARP members.

Angus Worthing, MD, chair of the ACR Government Affairs Committee, underscores the success the committee has had in the past year and the essential roles that members and patients have played in achieving this success. “Rheumatologists and our patients have truly punched above our weight by securing critical advocacy victories despite our small numbers,” he says. “There’s no substitute for individual participation in advocacy to keep the momentum going.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The session will be moderated by Christina Downey, MD, assistant professor of medicine at Loma Linda University Medical Center, California, and Courtney Crayne, MD, a pediatric rheumatologist at the University of Alabama, Birmingham. Three presentations will update attendees on advocacy achievements and the work of the Government Affairs Committee, teach strategies to assess legislation that affects rheumatology and help members learn to engage in advocacy work on behalf of the ACR.

Advocacy Achievements & Ongoing Efforts
Dr. Worthing will open the session with a recap of the front-line victories won on behalf of rheumatologists and patients over the past year. These include better access to and reimbursement for evaluation and management services, as well as protection of infusion drug services and ultrasound.

“I’ll also review current challenges facing the rheumatology profession in Washington, D.C., such as the workforce gap, step therapy and administrative headaches, including prior authorization. All of these are barriers to patient treatment,” says Dr. Worthing.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Ongoing areas of focus for the committee include drug pricing, patient access to therapies (e.g., biologics, small-molecule targeted immune modulators), research funding for rheumatology, Medicare reimbursement for cognitive services, diagnostic ultrasound and workforce shortages in rheumatology.

Dr. Worthing will also describe why advocacy work is important to members, their patients and their practices.

Get Involved
Two presentations will help members learn how to support advocacy efforts. Will Harvey, MD, MSc, director of clinical informatics integration at Tufts Medical Center, Boston, will speak about practical ways for members to make their voices heard. Attendees will learn how to use the ACR Legislative Action Center and Regulations.gov to submit comments on current bills and regulations, as well as how to advocate for rheumatology through social media.

State Rep. Kim Schofield (D-Atlanta) will talk about advocacy efforts from the perspective of a lawmaker and what it means to hear about constituent’s concerns.

The session will also include a short advocacy training session to give attendees a brief hands-on lesson in how to engage in advocacy work.

Take Home Message
“We hope members leave the session with an understanding of how the policies put in place at the federal level affect how rheumatologists practice medicine and get paid,” says Dr. Downey. “We hope members also leave the session feeling empowered that they have a voice in how policies are written and implemented.”


Mary Beth Nierengarten is a freelance medical journalist based in Minneapolis.

Pages: 1 2 | Multi-Page

Filed Under: Meeting Reports Tagged With: 2019 ACR/ARP Annual Meeting, Advocacy, Government Affairs Committee

You Might Also Like:
  • Hot Topics, Fresh Formats: ACR/ARP Annual Meeting Clinical Session Preview
  • Annual Meeting Preview: Maximizing Reimbursement Under MACRA, MIPS & APMs
  • Sit Back & Enjoy Learning at the 2019 ACR/ARP Annual Meeting
  • 2013 ACR/ARHP Annual Meeting Scientific Program Preview

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)